Bayer | Ophthalmology

This AMD Awareness Month and Low Vision Month, we’re shining a light on the impact of age-related macular degeneration and the millions of individuals living with vision impairment. While AMD can impact independence and quality of life, raising awareness and ensuring early diagnosis and appropriate care can lead to better outcomes. We remain committed to advancing eye health, supporting individuals with vision loss, and partnering with communities to help protect sight and enhance quality of life. Swipe to learn more about AMD. #AMDAwarenessMonth #LowVisionMonth #EyeHealth #VisionCare #PatientSupport

Reducing treatment burden is essential to improving quality of life for people with neovascular (wet) age-related macular degeneration (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO).   In this new article, our Global Ophthalmology Lead, Anna Braeken, shares a personal and professional perspective on why this matters and how innovations like extended treatment intervals and more efficient clinic processes can make a real difference.   Discover how reducing treatment burden can meaningfully impact patients and healthcare professionals in the full article: https://bit.ly/3LM5KhZ    #RetinalHealth #OphthalmologyInsights #PatientExperience 

Join Prof. Anat Loewenstein and Prof. Sobha Sivaprasad in an insightful episode where they discuss the Vision Academy guidance for the management and treatment of central serous chorioretinopathy (CSC).   Learn about the pathogenesis of CSC, how to identify different subtypes, and distinguish them from conditions on the pachychoroid spectrum, and the current evidence for treatment options.   Listen and learn at https://bit.ly/3NTCF4B (Spotify) and https://bit.ly/3NKLi1p (Apple)!   Click to read the Vision Academy Viewpoint (https://bit.ly/446X1MZ) and publication (https://lnkd.in/ehfdkSPP).   #Ophthalmology #VisionAcademy #EyeCare

Are you ready to join us in addressing a critical component of sustaining the delivery of high-quality patient care amid rising global demand? Don’t miss out on this opportunity to get involved!    If you are a specialist, fellow, resident, postgraduate, nurse, or technician working in ophthalmology who regularly interacts with and provides care for patients, click this link to complete the HCP Barometer Survey: https://lnkd.in/e_Urq6ux     Developed as part of the HCP Barometer Program, driven by a diverse coalition of experts, it analyses the well-being and needs of you, your peers, and other HCPs around the world in 15 minutes.    To hear from Prof. Adrian Koh about how evidence-based insights today can have a long-lasting impact for the entire community, watch the video below.     To help uncover meaningful and actionable insights into the needs and experiences of HCPs around the globe, please share the survey with your colleagues. 

We are pleased to share that the A Chat with Anat podcast series has reached an exciting milestone – 1,500 downloads!   This achievement reflects the many insightful discussions and thought-provoking topics explored throughout the series, and we are grateful to everyone who has tuned in, shared episodes, and supported these conversations.   The podcast has featured a wide range of perspectives across vision health, policy, ageing, and patient experience, and we look forward to continuing to build on this momentum.   Explore and listen to the podcast episodes below: Apple: https://bit.ly/3QHI8tH Spotify: https://bit.ly/3XwbC1s   Stay tuned for more conversations coming later this year.   #Ophthalmology #EyeCare

Revisit an insightful episode which explores how AI can transform patient care and optimize clinic operations.     To give insights on this topic, Prof. Anat Loewenstein is joined by Dr. John Kitchens, Vitreoretinal Surgeon with Retina Associates of Kentucky, USA.    Listen on Spotify (https://bit.ly/3DMUugV) or Apple (https://bit.ly/3DPySR6) to hear them discuss the importance of holistic patient care, and the latest advances in home monitoring technologies in retinal disease.    Explore and listen to more episodes of the podcast here:  Apple: https://bit.ly/3QHI8tH   Spotify: https://bit.ly/3XwbC1s     #Ophthalmology #EyeCare 

We are delighted to share that our manuscripts on neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) have now surpassed 10,000 combined accesses – an important milestone that highlights the growing interest in advancing our understanding of patient experiences and treatment journeys across retinal diseases.      We are grateful to everyone who has taken the time to read, share, and reflect on these findings, and we appreciate the continued engagement from the ophthalmology community.    Looking ahead, we are excited to build on this momentum. Additional manuscripts are currently in development and will offer deeper analyses of the data, including exploration of the differing experiences of patients living with nAMD and DME, insights into how various treatment regimens shape patients’ perceptions of their disease and treatment, and new insights into predictors of non-adherence to treatment.     These forthcoming publications aim to further support clinicians, researchers, and advocates in improving patient-centred care.    We invite you to revisit the published manuscripts and stay tuned for further updates as new analyses become available.  Read the current manuscripts here:  nAMD: https://bit.ly/4kovvkJ  DME: https://bit.ly/4iqpIJs

As we look ahead to 2026, we are pleased to share several meaningful updates on the horizon that will continue to support our efforts to advance understanding and awareness of vision health.    New translations of the AMD Barometer resources will be added to the Resource Zone on our website, expanding global access to this important body of work. In addition, further episodes of A Chat with Anat will be released throughout the year, offering fresh insights, conversations, and perspectives from experts and advocates across the vision health community.     We invite you to follow this page to stay informed about upcoming updates, new initiatives, and opportunities to engage with the AMD Barometer program.     Explore the AMD Barometer website: https://bit.ly/4kmWjlj       Listen to the Chat with Anat podcast:  Apple: https://bit.ly/3QHI8tH    Spotify: https://bit.ly/3XwbC1s   

Did you know that 90% of vision loss is preventable or treatable?         At Bayer, inclusion is at the heart of our mission to advance eye health. We collaborate with eye-care professionals and global partners to remove barriers, improve access, and make inclusive vision care a reality for all.        #VisionForAll #InclusiveHealthcare #BetterEyeCare #BayerOphthalmology